đ Common Names (6 Languages)
â Evidence-Based Benefits
Powerful anti-inflammatory for arthritis and inflammatory bowel disease. Systematic review and meta-analysis of RCTs shows significant pain reduction (-15 to -20mm VAS scale) and improved function in osteoarthritis (PMID: 20419483). Clinical trials in ulcerative colitis show remission rates comparable to mesalamine (PMID: 11302778). May benefit asthma and inflammatory conditions. Superior to placebo with fewer adverse effects than NSAIDs.
đ Want the Complete Guide?
Get our comprehensive Medicinal Herb Profiles PDF Book featuring all 50 herbs with detailed information, clinical trials, safety data, and multilingual names.
- â 50 Complete Herb Profiles
- â 700+ Research Citations
- â Evidence-Based Information
- â Instant Digital Download
Perfect for healthcare professionals, students & herbal medicine enthusiasts
đŦ Clinical Trials & Evidence
âī¸ Evidence-Based Research: Clinical trials provide the highest level of evidence for herbal efficacy and safety. The trials listed below represent peer-reviewed research registered on ClinicalTrials.gov. Each trial includes detailed protocols, patient populations, interventions tested, and measurable outcomes. Click links to access full trial details and published results.
Meta-analysis: Significant OA pain reduction
RCT: Ulcerative colitis remission
đ Drug Interactions
Important: Always inform your healthcare provider about all herbs and supplements you are taking.
NSAIDs (Ibuprofen, Naproxen, Diclofenac)
Effect: Additive anti-inflammatory effects
Mechanism: Complementary pathways (boswellia: 5-LOX; NSAIDs: COX)
Action: May allow NSAID dose reduction under medical supervision. Monitor for GI effects though boswellia is gentler
Evidence: Clinical trials show synergy (PMID: 29316908)
Immunosuppressants (Methotrexate, Biologics)
Effect: May affect immune modulation
Action: Generally safe to combine for RA but consult rheumatologist
Anticoagulants
Effect: Theoretical bleeding risk (minimal evidence)
Action: Monitor if using high doses with warfarin
Medications metabolized by CYP enzymes
Effect: Boswellic acids may affect drug metabolism
Action: Monitor effectiveness of other medications
â ī¸ Safety Information
Adverse Events
Generally well tolerated with minimal side effects. Mild gastrointestinal upset (nausea, diarrhea, acid reflux) in ~5% users - take with food. Rare skin rash (~2%). No serious adverse events in systematic reviews. Safer GI profile than NSAIDs.
â Contraindications
Caution with NSAIDs (theoretical additive GI effects). Avoid in pregnancy (may stimulate menstrual flow). May interact with anticoagulants and immunosuppressants. Generally safe but monitor with other anti-inflammatory medications.
đ§Ŧ Mechanism of Action
Boswellic acids (especially AKBA - 3-O-acetyl-11-keto-β-boswellic acid) inhibit 5-lipoxygenase (5-LOX), reducing leukotriene synthesis and inflammation. Does NOT inhibit COX pathways like NSAIDs - different mechanism. Anti-inflammatory via NF-ÎēB inhibition. May inhibit cartilage degradation enzymes.
đ Dosage & Administration
300-500mg extract (60-65% boswellic acids, min 10% AKBA) 2-3 times daily with meals. Total daily: 900-1500mg. For osteoarthritis: 1000mg total daily standardized extract. For IBD: 900-1200mg daily. Effects on pain/inflammation after 4-8 weeks.
âī¸ Note: Consult healthcare provider for appropriate dosing, especially if taking medications.
Disclosure: This page contains affiliate links. As an Amazon Associate, we earn from qualifying purchases at no additional cost to you. This helps support our educational content.
Data Retrieval: November 29, 2025 | Compiled by: Sheraz Ahmed
License: CC BY-SA 4.0
Citation: Ahmed, S. (2025). Medicinal Herbs Database. Clinical Corner. https://welovelmc.com/medical-tools.htm